2010
DOI: 10.1016/j.jneumeth.2010.07.021
|View full text |Cite
|
Sign up to set email alerts
|

Spatially pathogenic forms of tau detected in Alzheimer's disease brain tissue by fluorescence lifetime-based Förster resonance energy transfer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 52 publications
0
3
0
Order By: Relevance
“…[69] FRET probes have been developed to interrogate a wide variety of processes in cellular signaling. [70,71] We can also use FRET to examine causes, treatments and potential diagnostic tools of disease [72][73][74] and in pharmaceutical studies in high throughput screening platforms for compounds or drug screening. [20,75,76] FRET is also being paired with other detection methods for faster and more accurate acquisition of information.…”
Section: State Of the Art Fret Approachesmentioning
confidence: 99%
“…[69] FRET probes have been developed to interrogate a wide variety of processes in cellular signaling. [70,71] We can also use FRET to examine causes, treatments and potential diagnostic tools of disease [72][73][74] and in pharmaceutical studies in high throughput screening platforms for compounds or drug screening. [20,75,76] FRET is also being paired with other detection methods for faster and more accurate acquisition of information.…”
Section: State Of the Art Fret Approachesmentioning
confidence: 99%
“…Confocal FRET microscopy was used to track the internalization of transferrin receptor-ligand complexes in live cells (27,33). FRET imaging has also been used to investigate the causes along with potential diagnostic tools and treatments for diseases (34)(35)(36). In the Alzheimer's disease study, advanced fluorescence lifetime-based FRET imaging enabled the detection of the spatial abnormalities of tau molecules as pathogenic markers in tissue sections (36).…”
Section: Introductionmentioning
confidence: 99%
“…FRET imaging has also been used to investigate the causes along with potential diagnostic tools and treatments for diseases (34)(35)(36). In the Alzheimer's disease study, advanced fluorescence lifetime-based FRET imaging enabled the detection of the spatial abnormalities of tau molecules as pathogenic markers in tissue sections (36). In pharmaceutical research, FRET imaging is used extensively in high throughput or content screening platforms for compound or drug screening (37)(38)(39).…”
Section: Introductionmentioning
confidence: 99%